Inicio › Cáncer de orofaringe › Nueva Jersey
Ensayos clínicos de Cáncer de orofaringe en Nueva Jersey
8 estudios sobre Cáncer de orofaringe buscan participantes en Nueva Jersey.
Ciudades en Nueva Jersey
Texto oficial del estudio (inglés)
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
- Cooper Hospital University Medical Center, Camden
- Jersey City Medical Center, Jersey City
- Cooperman Barnabas Medical Center, Livingston
- y 4 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT07195734Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
- Rutgers Cancer Institute of New Jersey, New Brunswick
- Rutgers New Jersey Medical School, Newark
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT05172245E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
- Rutgers Cancer Institute, New Brunswick
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jun 2026 · NCT05639972E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
- Rutgers Cancer Institute, New Brunswick
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jun 2026 · NCT05686226A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 may 2026 · NCT06984861A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
- Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 abr 2026 · NCT05491512A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)
- Memorial Sloan Kettering Basking Ridge (Limited protocol activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 abr 2026 · NCT05307939A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 feb 2026 · NCT07063212De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.